summary: The authors studied the cognitive performance of patients with relapsing MS over 10 years. Interestingly, they did not find any significant cognitive deterioration in these patients.

authors: Schwid SR, Goodman AD, Weinstein A, McDermott MP, Johnson KP; for the Copaxone Study Group.

source: J Neurol Sci. 2007 Feb 27

weblink: click here

category: Clinical Trials and Therapeutics

related research news: click here

glossary: